RAP1 is highly expressed in high-grade NSCLC samples, facilitates NF-κB activation which is required for the proliferation of NSCLC cells, upregulates BCL-2 expression and mediates the resistance of NSCLC cells to CP. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.